← Back to Clinical Trials
Recruiting NCT05805319
Dietary Intervention for NSCLC Patients Treated With ICI
Trial Parameters
Condition Non Small Cell Lung Cancer
Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-04-27
Completion 2025-03-30
Interventions
increasing total fiber intake
Brief Summary
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.
Eligibility Criteria
Inclusion Criteria: * Signed, informed consent * Age 18 years or older * Confirmed histological diagnosis of non-small cell lung cancer (NSCLC); Treatment with standard-of-care ICI * Ability to eat solid foods Exclusion Criteria: * Severe dietary allergies (e.g. shellfish, nuts, seafood) * Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Related Trials
NCT06476093
SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
View Trial →
NCT06272864
BostonGene and Exigent Genomic INsight Study
View Trial →
NCT06809764
Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m N
View Trial →